Oxybutynin XL/Lyrinel XL
Lyrinel XL contains a medicine called Oxybutynin which relaxes the muscles of the bladder, causing the bladder wall to contract less quickly. This allows the bladder to store more urine without feeling the need to urinate. Oxybutynin is prescribed for problems caused by an overactive bladder, such as urinary incontinence and enuresis. Urinary incontinence, which is the result of an overactive bladder, is often also called urge incontinence. The patient often has to urinate even though the bladder is not yet full. Then it may happen that the urine cannot be stored well. Because Oxybutynin relieves the urge to urinate, incontinence decreases. Lyrinel XL is a modified release formulation meaning that it releases the drug in controlled fashion and may not require administration as frequently as other Oxybutynin formulations.

Brand | Medicine Strength | Size | Price |
---|---|---|---|
Lyrinel XL | 10mg | 30 Tablets | 45.00 |
Lyrinel XL | 10mg | 60 Tablets | 86.00 |
Lyrinel XL | 10mg | 90 Tablets | 120.00 |
Lyrinel XL | 5mg | 30 Tablets | 28.00 |
Lyrinel XL | 5mg | 60 Tablets | 51.00 |
Lyrinel XL | 5mg | 90 Tablets | 74.00 |
It looks like you missed filling in questions from the last consultation.Click Here to submit your response.
Notify me once available
No hidden fees
Secure checkout
UK Regulated online pharmacy
Trusted by over 100,000+ customers
Lyrinel XL contains a medicine called Oxybutynin which relaxes the muscles of the bladder, causing the bladder wall to contract less quickly. This allows the bladder to store more urine without feeling the need to urinate. Oxybutynin is prescribed for problems caused by an overactive bladder, such as urinary incontinence and enuresis. Urinary incontinence, which is the result of an overactive bladder, is often also called urge incontinence. The patient often has to urinate even though the bladder is not yet full. Then it may happen that the urine cannot be stored well. Because Oxybutynin relieves the urge to urinate, incontinence decreases. Lyrinel XL is a modified release formulation meaning that it releases the drug in controlled fashion and may not require administration as frequently as other Oxybutynin formulations.
Oxybutynin works on the contractions of the bladder and delays the desire to urinate. It can be used to treat some types of incontinence and other urinary problems.
Oxybutynin has both a direct antispasmodic effect on the smooth muscle of the bladder detrusor and an anticholinergic by blocking the muscarinic effects of acetylcholine on smooth muscle. These properties cause relaxation of the detrusor muscle of the bladder. In patients with an unstable bladder, Oxybutynin increases the capacity of the bladder and reduces the incidence of spontaneous contractions of the detrusor muscle, thus delaying the need to empty the bladder.
Oxybutynin can be used to treat: involuntary leakage of urine (urinary incontinence), increased need or urge to urinate, involuntary loss of urine at night, when other treatments have not worked.
Always use this medicine exactly as your doctor or pharmacist has told you. If in doubt, consult your doctor or pharmacist again. Remember to take your medication. Oxybutynin must be taken regularly following the instructions of your doctor throughout the treatment. Oxybutynin is indicated for oral use only. The taste of the tablets is not pleasant and must be swallowed whole with a significant amount of liquid - half a glass of water, regardless of food intake. If you think that the action of Oxybutynin is too strong or weak, tell your doctor or pharmacist.
Like all medicines, this medication can cause side effects, although not everybody gets them.
Very common side effects:
Dry mouth, constipation, nausea, dizziness, blurred vision, difficulty urinating, dry skin.
Common side effects:
Headache, drowsiness, asthenia, diarrhea, vomiting, dysgeusia (a disorder of the sense of taste), flatulence (gases), states of confusion, atrial arrhythmia, nodal arrhythmia, supraventricular extrasystole, dry eyes, urinary retention, hematuria (presence of blood in the urine), nocturia (need to urinate at night), pyuria (presence of leukocytes in the urine), pharyngitis (inflammation of the pharynx), redness of the skin.
Uncommon side effects:
Anxiety, confusion, nervousness, agitation, difficulty sleeping, rhinitis, abdominal discomfort, anorexia (lack of appetite), decreased appetite, dysphagia (difficulty swallowing), cough, epistaxis (nosebleed), vulvovaginitis (inflammation of the vulva and of the vagina).
Rare side effects:
Panic reaction, mental confusion, hallucinations, disorientation, memory impairment, memory loss, abnormal tiredness, poor concentration, photosensitivity (sensitivity to light), thrombocytopenia (reduction in the number of platelets).
Frequency not known:
Gastroesophageal reflux, gastritis, pseudo-obstruction in patients at risk (in elderly patients or patients with constipation and in treatment with other medications that decrease intestinal motility), agitation, seizures, anxiety, nightmares, paranoia (mistrust, delusions), cognitive disorders in elderly patients, symptoms of depression and oxybutynin dependence (in patients with a history of substance abuse or dependence), tachycardia (increased heart rate), arrhythmia, angle-closure glaucoma (increased intraocular pressure), mydriasis (dilation of the pupil), intraocular hypertension, urinary tract infection, adverse reactions such as generalized skin erythema, urticaria, angioedema (generalized inflammation of the feet, hands, throat, lips and respiratory tract), skin rashes, hypohidrosis (decreased sweat production), heat stroke, hypersensitivity
Oxybutynin should be used with caution in elderly patients, patients with Parkinson's disease, and children who are at increased risk of adverse reactions to the product, as well as in patients with autonomic neuropathies, severe gastrointestinal motility disorders, kidney or liver failure.
Gastrointestinal disorders: Anticholinergic drugs, such as oxybutynin, may decrease gastrointestinal motility and should be used with caution in patients with gastrointestinal obstructive disorders, intestinal atony, and ulcerative colitis.
Oxybutynin should be used with caution in patients with clinically significant bladder obstruction since anticholinergic drugs may aggravate this obstruction and cause urinary retention.
You can buy Lyrinel XL Tablets online through one of the UK’s leading online pharmacies, Pharmacy Planet. It's easy and convenient. You will need to fill out a short assessment and the item will be delivered directly to your door. If you want to buy these Genito-Urinary Tablets online, use Pharmacy Planet, a UK pharmacy you can trust.

clinical consultation
Answer a few questions on your health and your fitness goals.

assessment
Our clinicians will review your clinical questionnaire to make sure treatment is right for you.

aboard!
Once approved, you will access our wealth of experience and resources curated by our team and begin your clinical weight loss journey.
Need Help?

Start your weight loss journey heading in the right direction. Our team are here to help. Whether you’re unsure about which medicine is right for you or need help navigating the world of weight loss drugs, our team are on hand to help you make the right decision. We can put you in touch with one of our experienced weight loss clinicians so you can be sure you’re making the best decision with the most accurate information.
To get in touch, contact our Customer Service team on 0800 978 8956 or email headoffice@pharmacyplanet.com.
References:
- Healthy Weight Loss In Depth - Mayo Clinic
- Orlistat-associated adverse effects and drug interactions: a critical review - PubMed - Theodosios D Filippatos 1, Christos S Derdemezis, Irene F Gazi, Eleni S Nakou, Dimitri P Mikhailidis, Moses S Elisaf
- Weight Loss Medicine - Patient Info - Authored by Dr Laurence Knott
- How to use Orlistat 120 Mg Capsule Fat Absorption Decreasing Agents - WebMD

Authored By
HARMINDER ‘HARMY’ KAUR
BSc(hons) Pharmacy
GPhC Number: 2061107

Reviewed By
GURDEV SEHMI
BSc Pharm, MRPharmS, Independent Prescriber, Superintendent Pharmacist, Clinical Lead
GPhC Number: 2050925